Because many of the BRCA1/2 mutation carriers in our cohort had undergone prophylactic surgery after inclusion in the study, there were too few cases of breast cancer for a meaningful comparison of the breast cancer risk between current smokers and non-smokers. This evidence concerns the gene BRCA1 and breast carcinoma.